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Objective To assess the prevalence of functional gastrointestinal disorders (FGIDs) in the first year of life and the
influence of different neonatal factors on development of FGIDs.
Study design A prospective cohort multicenter study including neonates, consecutively enrolled at birth, and fol-
lowed up until 1 year. Gestational age, neonatal antibiotic administration, duration of hospitalization, mode of
delivery, birth weight, and feeding pattern were recorded. FGIDs were classified according to Rome III criteria
and assessed at 1, 3, 6, and 12 months of life.
Results Among 1152 newborns enrolled, 934 (81.1%) completed the study, 302 (32%) were newborns born pre-
term, 320 (34%) had neonatal antibiotics, and 718 (76.9%) had at least 1 FGID according to Rome III criteria (443
[47.4%] infantile colic, 374 [40.0%] regurgitation, 297 [31.8%] infant dyschezia, 248 [26.6%] functional constipation,
and 34 [3.6%] functional diarrhea) throughout the first year of life. The proportion of infants born preterm presenting
with FGIDs (86%) was significantly greater compared with infants born full term (72.5%) (c2 = 21.3, P = .0001). On
multivariate analysis, prematurity and neonatal use of antibiotics was significantly associated with at least 1 FGID.
ConclusionsWe found a high rate FGIDs in infants, likely related to the population recruited, the long observation
period, the diagnosis based on Rome III criteria, and parental reports. Preterm delivery and neonatal use of antibi-
otics in the first months of life are associated with an increased incidence of FGIDs, particularly infantile colic and
regurgitation. In our population, cesarean delivery and feeding pattern at 1 month of life emerged as additional risk
factors for infant dyschezia and functional diarrhea. Other neonatal factors associated with FGIDs need to be further
explored. (J Pediatr 2019;-:1-8).F
unctional gastrointestinal disorders (FGIDs) include a variable combination of chronic or recurrent gastrointestinal
symptoms in the absence of structural or biochemical abnormalities. Despite heterogeneity in methods and definitions,
many infants <12 months are affected by FGIDs, with a reported overall prevalence of 50% in newborns born full term
and up to 73% with infantile colic and 87% with regurgitation in selected population.1,2
The 2006 Rome III criteria classified and clinically distinguished different FGIDs, in neonates and toddlers, including infant
regurgitation, infant rumination syndrome, cycling vomiting syndrome, infant colic, functional diarrhea, infant dyschezia, and
functional constipation.3 FGIDs often have a negative impact on infants’ and parents’ quality of life, potential long-term health
consequences, and increase in healthcare costs.4
The pathophysiology of FGIDs remains unclear. Different factors have been suggested as determinants, including genetic
predispositions, psychosocial factors, abnormal intestinal motility, visceral hyperalgesia, gut inflammation, intestinal micro-
biota, early stressful events, and trauma.5 There is evidence that early life events play a pivotal role in the programming of
different diseases later in life.6 Some authors speculated that the type of delivery, feeding practice, and early antibiotic admin-
istration may predispose infants to FGIDs.7 We performed a prospective multicenter cohort study to investigate the possible
relationship between neonatal factors (such as prematurity, antibiotic treatment, cesarean delivery, formula feeding, and hos-
pital stay) and the development of FGIDs in the first year of life.From the 1Unit of Pediatrics and Neonatology, “F. Del
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The study was carried out in 5 Italian pediatrics and neonatal
units (Varese, Milano, Parma, Bari, and Catanzaro) between
2014 and 2016. The institutional review boards of partici-
pating hospitals approved the study protocol; written
informed consent was obtained from parents of participants
before inclusion.Eligibility
Inclusion criteria were newborns born preterm (gestational
age between 25 and 36 weeks) or newborns born at full
term (gestational age ³37 weeks) at the same participants
hospitals, with Italian-speaking parents. Exclusion criteria
were severe acute infection or neonatal complications;
known genetic syndromes, congenital and/or malformative
disorders; surgery; major neurologic, immune, metabolic,
cardiac, or renal diseases; absence of parental consent; or
language difficulty. All newborns satisfying inclusion and
exclusion criteria were consecutively recruited during the
first days of life.Study Design
Gestational age, mode of delivery, neonatal complications,
birth weight, antibiotic use during the first week of life, dura-
tion of hospitalization at birth, and feeding pattern at
1 month of life were collected in all newborns enrolled via
hospital charts and direct interview of parents. At the time
of the study, a validated questionnaire for FGIDs in infants
was not available,8 and the Rome IV criteria had not yet
been published. Hence, FGIDs were clinically classified ac-
cording to Rome III criteria3 and assessed through a stan-
dardized interview to parents by a dedicated and ad hoc,
trained physician at each hospital to promote uniform docu-
mentation. Data were collected using the same specific form
at each clinical evaluation scheduled at 1, 3, 6, and 12 months.
For newborns born preterm, a clinical evaluation was sched-
uled with the same time interval based on chronologic age.
Review of hospital charts, outpatient clinic database, and a
phone interview also were used for unclear or missing data
during the follow-up period. Before starting the study, all
participant investigators discussed the design of the study
and reached a consensus on what to consider as FIGD and
specifically infantile colic, dyschezia, regurgitation, functional
diarrhea, and constipation, as well as data to be recorded.Primary and Secondary Outcomes
The primary outcome was to assess the prevalence of FGIDs
in a cohort of Italian infants born preterm and at term during
the first year of life, using the Rome III Criteria (Appendix 1;
available at www.jpeds.com). Secondary outcome was to
investigate the possible association between FGID
development and neonatal characteristics such as
gestational age, mode of delivery, birth weight, antibiotics
use during the first week of life, duration of hospitalization
after birth, and feeding pattern at 1 month of life.2Statistical Analyses
The completed questionnaires were uploaded as an Excel
spreadsheet (Microsoft, Redmond, Washington) and data
were analyzed by Stata SE14 software (StataCorp LLC, Col-
lege Station, Texas). Continuous variables were described
as mean  SD, categorical variables as proportions, with
the indication of 95% CI where deemed appropriate.
Skewness and kurtosis tests were used to perform the
normality analysis of continuous variables and it was not
possible to set a normalization model. The Wilcoxon rank-
sum test (nonparametric) was used to compare not-normal
continuous variables between preterm and full-term births;
the c2 test was used to compare the proportions between
preterm and full-term births.
The association between FIGDs and gestation age (pre/
full-terms), delivery mode, feeding pattern, antibiotics use
during the first week of life, and duration of hospitalization
after birth was assessed by means of univariate log-
binomial regression analysis. The relative risk (RR) values
were estimated, with 95% CI and test z score performed.
Subsequently, for each outcome, a multivariate log-
binomial regressionmodel was created, using as determinants
the same variables used in the univariate log-binomial regres-
sion. The aRR (adjusted relative risk) values were estimated,
with 95% CI and the test z score performed. For all the tests, a
value of P < .05 was considered statistically significant.Results
Of the 1152 newborns enrolled in the study, 934 (81.1%)
completed the entire 12-month follow-up and were entered
in the final analysis; 632 of 934 (67.7%) infants were born
at full term and 302 of 934 (32.3%) were born preterm. Of
the 632 infants born full term, 521 were born between 37
and 40 weeks of gestation, and 117 (18%) were post-term
(eg, born at or beyond 41 weeks of gestation). Among the
934 infants who completed the study, 320 (34.3%) had anti-
biotics in the first week of life and 373 (39.9%) were born by
cesarean delivery.
Demographic characteristics of participants are shown in
Table I. As expected, infants born preterm showed
significant difference in gestational age, birth weight,
hospital stay, rate of cesarean delivery, rate of
breastfeeding, and antibiotic use (Table I). Overall, in 718
of 934 participants (76.9%) at least 1 FGID was reported
during the first 12 months of life, and in 369 (39.5%)
infants, multiple FGIDs coexisted.
Infant colic and regurgitation were the most commonly
recorded disorders, in 443 of 934 (47.4%) and 372 of 934
(40.0%) participants, respectively. Infant dyschezia, func-
tional constipation, and functional diarrhea were reported
in 297 of 934 (31.8%), 248 of 934 (26.6%), and 34 of 934
(3.6%) participants, respectively. Of these FGIDs, 99% of
infantile colic, 96% of regurgitation and dyschezia, and
80% for functional constipation were reported during the
first 3 months of life.Salvatore et al
Table I. Demographic characteristics at baseline, according to the 2 groups of infants born preterm and full term
Variables Preterm (n = 302) Full term (n = 632) Total (n = 934) Test P
Gestational age, d, mean  SD 226.4  20.2 277.7  8.0 261.1  27.4 z = 24.8 .000
Male, n (%) 140 (46.4) 300 (47.5) 494 (52.9) c2 = 0.1 .750
Female, n (%) 162 (53.6) 332 (52.5) 440 (47.1)
Cesarean delivery, n (%) 210 (69.5) 163 (25.8) 373 (39.9) c2 = 163.0 .000
Vaginal birth, n (%) 92 (30.5) 469 (74.2) 561 (60.1)
Birth weight, g, mean  SD 1755.0  626.2 3249.9  416.3 2766.5  856.2 z = 23.4 .000
Exclusive formula feeding at 1 mo, n (%; 95% CI) 162 (53.6; 47.8-59.4) 114 (18.1; 15.1-21.3) 276 (29.5; 26.6-32.6) c2 = 181.7 .000
Exclusive breastfeeding at 1 mo, n (%; 95% CI) 46 (15.2; 11.4-19.8) 375 (59.3; 55.4-63.2) 421 (45.1; 41.9-48.3)
Mixed feeding at 1 mo, n (%; 95% CI) 94 (31.2; 25.9-36.7) 143 (22.6; 19.4-26.1) 238 (25.4; 22.7-28.4)
Antibiotic use, n (%; 95% CI) 179 (59.3; 53.5-64.9) 141 (22.3; 19.1-25.8) 320 (34.3; 31.2-37.4) c2 = 124.0 .000
Hospital stay, d, mean  SD 28.8  22.4 4.7  9.5 12.5  18.7 z = 22.2 .000
Hospital stay c2 = 440.4 .000
£4 d, n (%) 31 (10.3) 521 (82.4) 552 (59.1)
>4 d, n (%) 271 (89.7) 111 (17.6) 382 (40.9)
- 2019 ORIGINAL ARTICLESEvolution of FGIDs during the clinical follow-up is shown
in Figure 1. Among the 5 hospitals, the incidence of FGIDs as
well as the percentage of neonates born preterm was not
homogenous (Appendix 2; available at www.jpeds.com).
The proportion of infants born preterm (86.1%) present-
ing FGIDs throughout the study was significantly (c2 = 21.3,
P = .0001) greater compared with infants born full term
(72.5%). However, the average number of FIGDs was
1.9  0.9, without any significant difference between groups
(z = 0.3; P = .773; Table II).Figure 1. Multivariate analysis for risk factors associated with FG
Neonatal Antibiotics and Prematurity Are Associated with an Incr
the First Year of LifeWe observed a significant difference in the proportion of
infants affected by infant colic and regurgitation between
the 2 groups of infants born preterm and full term
(P < .05; Table II). Furthermore, the incidence of FGIDs
among the infants born premature was significantly
different based on different gestational age (c2 = 10.0;
P = .012). However, regurgitation was reported more
frequently in neonates born at 28-30 weeks compared with
neonates born earlier (<28 weeks) or later preterm
(Table III).IDs.
eased Risk of Functional Gastrointestinal Disorders in 3
Table II. Proportion (%) of infants with FIGDs, according to the different FIGD and group
Variables Preterm (n = 302) Full term (n = 632) Total (n = 934) Test P
Regurgitation, n (%; 95% CI) 138 (45.7; 40.0-51.5) 236 (37.3; 33.6-41.2) 374 (40.0; 36.9-43.3) c2 = 5.9 .015
Infant colic, n (%; 95% CI) 178 (58.9; 53.2-64.5) 265 (41.9; 38.0-45.9) 443 (47.4; 44.2-50.7) c2 = 23.7 .000
Functional diarrhea, n (%; 95% CI) 10 (3.3; 1.6-6.0) 24 (3.8; 2.4-5.6) 34 (3.6; 2.5-5.0) c2 = 0.1 .711
Infant dyschezia, n (%; 95% CI) 98 (32.5; 27.2-38.0) 199 (31.5; 27.9-35.3) 297 (31.8; 28.8-34.9) c2 = 0.1 .768
Functional constipation, n (%; 95% CI) 80 (26.5; 21.6-31.8) 168 (26.6; 23.2-30.2) 248 (26.6; 23.7-29.5) c2 = 0.0 .976
At least 1 FIGD, n (%; 95% CI) 260 (86.1; 81.7-89.8) 458 (72.5; 68.8-75.9) 718 (76.9; 74.0-79.5) c2 = 21.3 .000
Number of FIGDs diagnosed, mean  SD 1.9  0.9 1.9  1.0 1.9  0.9 z = 0.3 .773
Variables in bold indicate statistical significance.
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greater rate of regurgitation (c2 = 6.6; P = .010) and at least
1 FIGD (c2 = 6.7; P = .010) in infants born at or beyond
41 weeks of gestation compared with infants born between
37 and 40 weeks of gestation (Table IV).
Risk Factors for FGIDs
On univariate analysis (Table V), FGIDs were significantly
associated with preterm birth (RR = 1.2; P < .0001),
cesarean delivery (RR = 1.1; P < .0001), exclusive formula
feeding (RR = 1.1; P = .010), use of neonatal antibiotics
(RR = 1.2; P < .0001), and hospitalization longer than
4 days (RR = 1.1; P < .0001). In particular, regurgitation
was significantly associated with preterm birth (RR = 1.2;
P = .013) and use of neonatal antibiotics (RR = 1.2;
P = .007); infant colic was associated with preterm birth
(RR = 1.4; P < .0001), cesarean delivery (RR = 1.2;
P = .003), exclusive (RR = 1.3; P = .006) or mixed formula
feeding (RR = 1.2; P = .011), use of neonatal antibiotics
(RR = 1.3; P < .0001), and hospitalization longer than
4 days (RR = 1.3; P < .0001). Functional diarrhea was
associated only with exclusive formula feeding (RR = 2.4;
P = .014). No other significant associations were found
(P > .05).
Multivariate Analysis for Risk Factors Associated
with FGIDs
On multivariate analysis (Table VI), prematurity and
neonatal use of antibiotic was associated with at least 1
FGID (aRR = 1.2; P = .001). Regurgitation was
significantly associated with use of neonatal antibiotics
(aRR = 1.3; P = .022); infant colic with prematurityTable III. Proportion (%) of infants born preterm with FIG
Gestational
ages, wk
Regurgitation Infant colic
Functional
diarrhea
n (%) 95% CI n (%) 95% CI n (%) 95%
<28 (n = 24) 10 (41.7) 22.1-63.4 17 (70.8) 48.9-87.4 1 (4.2) 0.1-2
28-30 (n = 60) 33 (55.0) 41.6-67.9 37 (61.7) 48.2-73.9 1 (1.7) 0.0-8
31-33 (n = 106) 44 (41.5) 32.0-51.5 58 (54.7) 44.8-64.4 3 (2.8) 0.6-8
34-36 (n = 106) 48 (45.3) 35.6-55.2 63 (59.4) 49.5-68.9 4 (3.8) 1.0-9
Test c2 P c2 P c2 P
3.0 .391 2.4 .498 0.7 .848
4(aRR = 1.3; P = .012) and use of neonatal antibiotics
(aRR = 1.2; P = .006); functional diarrhea with exclusive
formula feeding (aRR = 3.1; P = .004), and infant
dyschezia with cesarean delivery (aRR = 1.2; P = .048)
and exclusive breast milk (aRR = 0.8; P = .044). No
other significant associations were found (P > .05).
Multivariate analysis for risk factors associated with
FGIDs is shown in Figure 2.
Discussion
We found a high incidence of FGIDs in our cohort of infants
prospectively evaluated from birth to 12 months of life
and characterized by a high prevalence (32%) of newborns
born preterm. Data on neonates born preterm with FGIDs
are currently very limited, and this population often
appeared in the exclusion criteria. However, as they are
exposed to multiple factors suggested to influence gastroin-
testinal homeostasis, pain perception, and sensitivity,5-7 we
tried to enroll a high number of neonates born preterm, hy-
pothesizing that they would be the most vulnerable popula-
tion for the development of FGIDs. Moreover, in our
population 320 (34.3%) had antibiotics in the first week of
life and 373 (39.9%) were born by cesarean delivery, 2
additional factors partially related to our large proportion
of newborns born preterm.
Approximately 75% of participants experienced at least 1
FGID; infantile colic and regurgitation were the most
commonly reported gastrointestinal symptoms, occurring
particularly in infants born preterm and in the first 3 months
of life. To the best of our knowledge, this is the first study
showing that both preterm delivery and neonatal use ofDs, according to the different gestational age at birth
Infant dyschezia
Functional
constipation At least 1 FIGD
CI n (%) 95% CI n (%) 95% CI n (%) 95% CI
1.1 10 (41.7) 22.1-63.4 7 (29.2) 12.6-51.1 23 (95.8) 78.9-99.9
.9 23 (38.3) 26.1-51.8 17 (28.3) 17.5-41.4 58 (96.7) 88.5-99.6
.0 33 (31.1) 22.5-40.9 26 (24.5) 16.7-33.8 88 (83.0) 74.5-89.6
.4 31 (29.3) 20.8-38.9 27 (25.5) 17.5-34.9 87 (82.1) 73.4-88.8
c2 P c2 P c2 P
2.4 .488 0.4 .934 10.0 .012
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Table IV. Proportion (%) of infants born full term with FIGDs, according to the different gestational age at birth
Full term newborns
gestational age
Regurgitation Infant colic
Functional
diarrhea Infant dyschezia
Functional
constipation At least 1 FIGD
n (%) 95% CI n (%) 95% CI n (%) 95% CI n (%) 95% CI n (%) 95% CI n (%) 95% CI
Post-term
(n = 117)
41-42 wk
56 (47.9) 38.5-57.3 56 (47.9) 38.5-57.3 5 (4.3) 1.4-9.7 40 (34.2) 25.7-43.5 34 (29.1) 21.0-38.2 96 (82.1) 73.9-88.5
Full term
(n = 521)
37-40 wk
183 (35.1) 31.0-39.4 212 (40.7) 36.4-45.0 20 (3.8) 2.4-5.9 160 (30.7) 26.8-34.9 137 (26.3) 22.6-30.3 366 (70.3) 66.1-74.1
Test c2 P c2 P c2 P c2 P c2 P c2 P
6.6 .010 2.0 .155 0.0 .794 0.5 .508 0.4 .542 6.7 .010
- 2019 ORIGINAL ARTICLESantibiotics determine an increased risk of the development of
FGIDs in infants.
FGIDs are common disorders in adults and children.
Gastrointestinal infection9,10 and early life events such as
gastric suction, cow milk protein allergy,11 inflammation,12
trauma,13 and stress14 have been suggested to predispose to
visceral hyperalgesia and gastrointestinal symptoms later in
life.3,7,15 Two previous studies have assessed the prevalence
of FGIDs in Italian infants, including a small group of new-
borns born preterm.16,17 Iacono et al enrolled 2879 infants
and showed that, in the first 6 months of life regurgitation,
colic, constipation, and diarrhea occurred in 23%, 21%,
18%, and 4% of infants, respectively. The authors reported
an increased prevalence of regurgitation in infants who had
low birth weight and of diarrhea in newborns small for gesta-
tional age. However, the number of newborns born preterm
was not specified, and Rome III criteria were not used.16
Campanozzi et al recruited 2642 infants (27 infants born pre-
term) with a range of age from 0 to 12 months and followed
them up at 6 or 12, 18, and 24 months. Regurgitation was re-
ported in 12% of the population without a significant differ-
ence between the small group of infants born preterm and full
term. Rome II criteria were used to classify functional regur-
gitation, no data on other FGIDs were recorded, participantsTable V. Univariate analysis for risk factors associated with
Risk factors
Regurgitation Infant colic Functional di
RR (95% CI) P RR (95% CI) P RR (95% CI)
Preterm (yes/no) 1.22 (1.04-1.43) .013 1.41 (1.23-1.60) .000 0.87 (0.42-1.8
Cesarean delivery
(yes/no)
1.06 (0.91-1.25) .440 1.23 (1.07-1.40) .003 1.05 (0.54-2.0
Feeding pattern
Exclusive formula
vs breastmilk
1.15 (0.96-1.39) .129 1.25 (1.06-1.46) .006 2.42 (1.19-4.9
Mixed feeding vs
exclusive
breastmilk
1.14 (0.94-1.38) .190 1.24 (1.05-1.47) .011 0.44 (0.13-1.5
Neonatal antibiotics
(yes/no)
1.24 (1.06-1.45) .007 1.34 (1.17-1.53) .000 0.92 (0.45-1.8
Hospital stay >4 d
(yes/no)
1.13 (0.96-1.32) .132 1.31 (1.15-1.50) .000 1.01 (0.52-1.9
Variables in bold indicate statistical significance.
Neonatal Antibiotics and Prematurity Are Associated with an Incr
the First Year of Lifewere not recruited at birth, and the dropout of patients was
nearly 30%.17
Vandenplas et al identified 30 studies on epidemiology
of FGIDs in infants. In the first 6 months of age, approx-
imately 1 of 2 infants shows at least 1 FGID.1 Colic
showed a worldwide prevalence ranging from 2% to
73%, regurgitation from 3% to 87%, functional constipa-
tion from 1% to 39%, and functional diarrhea and dys-
chezia <10%.
We found a greater incidence rate of FGIDs than in the
previous studies.1-3,16,17 This difference could be related to
the characteristics of our population (one-third comprising
infants born preterm, one-third comprising neonates sub-
mitted to antibiotic treatment in the first week of life, and
40% born by cesarean delivery) and to the definition and
method of data collection. Moreover, it is noteworthy the
long observation period with cumulative incidence of FGIDs
derived by our prospective design assessing the occurrence of
FGIDs from 0 to 12 months.
Although use of a validated diary, such as the Barr diary,
would have been ideal and may have lowered the incidence
of FGIDs in our population, it was not possible to have par-
ents reliably complete this on a daily or weekly basis from 0 to
12 months.18FGIDs
arrhea Infant dyschezia
Functional
constipation At least 1 FGID
P RR (95% CI) P RR (95% CI) P RR (95% CI) P
0) .711 1.03 (0.84-1.26) .767 1.00 (.79-1.25) .976 1.19 (1.11-1.27) .000
5) .880 1.20 (1.00-1.45) .053 1.20 (0.97-1.48) .096 1.14 (1.07-1.22) .000
0) .014 1.00 (0.81-1.25) .956 1.14 (0.89-1.47) .310 1.11 (1.03-1.21) .010
6) .205 0.79 (0.62-1.02) .071 1.17 (0.90-1.52) .233 1.08 (0.99-1.18) .079
6) .811 1.13 (0.93-1.37) .219 1.02 (0.81-1.27) .872 1.18 (1.10-1.26) .000
8) .973 1.05 (0.87-1.27) .613 0.93 (0.75-1.16) .506 1.14 (1.07-1.22) .000
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Table VI. Multivariate analysis for risk factors associated with FGIDs
Risk factors
Regurgitation Infant colic Functional diarrhea Infant dyschezia
Functional
constipation At least 1 FGID
aRR (95% CI) P aRR (95% CI) P aRR (95% CI) P aRR (95% CI) P aRR (95% CI) P aRR (95% CI) P
Preterm (yes/no) 1.23
(0.97-1.58)
.093 1.28
(1.06-1.55)
.012 0.50
(0.18-1.40)
.186 0.91
(0.68-1.22)
.541 0.98
(0.70-1.36)
.891 1.15
(1.04-1.27)
.007
Cesarean delivery
(yes/no)
0.98
(0.81-1.17)
.795 1.06
(0.91-1.23)
.438 0.93
(0.45-1.93)
.840 1.23
(1.00-1.52)
.048 1.25
(0.99-1.58)
.066 1.04
(0.95-1.14)
.390
Feeding pattern
Exclusive formula
vs breastmilk
1.09
(0.89-1.35)
.405 1.11
(0.93-1.32)
.256 3.14
(1.44-6.88)
.004 0.9700
(0.76-1.24)
.832 1.17
(0.89-1.55)
.256 1.04
(0.96-1.14)
.316
Mixed formula
vs breastmilk
feeding
1.07
(0.87-1.31)
.501 1.10
(0.93-1.31)
.274 0.49
(0.14-1.77)
.279 0.76
(0.59-0.99)
.044 1.21
(0.92-1.59)
.168 1.04
(0.96-1.13)
.344
Neonatal antibiotics
(yes/no)
1.25
(1.03-1.52)
.022 1.24
(1.06-1.45)
.006 1.14
(0.51-2.56)
.749 1.20
(0.94-1.52)
.144 1.12
(0.85-1.46)
.426 1.16
(1.06-1.26)
.001
Hospital stay >4 d
(yes/no)
0.85
(0.66-1.09)
.192 0.94
(0.77-1.15)
.561 1.12
(0.41-3.09)
.827 0.98
(0.73-1.31)
.896 0.77
(0.55-1.09)
.144 0.92
(0.82-1.04)
.175
Variables in bold indicate statistical significance.
THE JOURNAL OF PEDIATRICS  www.jpeds.com Volume-The diagnosis of FGIDs relies on clinical criteria, with
exclusion of warning signs for organic diseases, because spe-
cific biomarkers or investigation are still lacking. Rome III
and, more recently, Rome IV criteria provide a detailed clas-
sification of different FGIDs at different ages. However, a het-
erogeneity of diagnosis or misclassification among different
physicians and an overestimation of prevalence of FGIDs
cannot be excluded.
As multiple genetic and environmental factors, parental
and physician perception, feeding patterns, and pharmaco-
logic treatments appeared to be determinants in the rate of
FGIDs in infants, our results should be cautiously considered
and should be replicated in other preterm populations beforeFigure 2. Temporal evolution of each FGID.
6a general conclusion can be drawn. The small number of pre-
vious studies assessing infantile dyschezia showed prevalence
of <10% but according to a recent study, in 17% of infants
symptoms preceding defecation were difficult to classify.19
Constipation was reported in up to 39% of infants. However,
another large prospective study is needed to determine
whether our greater incidence of dyschezia reflects a specific
figure of our population, a real increasing incidence of this
disorder, a greater parental awareness, or a better classifica-
tion from what was previously reported as functional consti-
pation in infants.
Gastrointestinal symptoms often are distressing to the in-
fant and parents, leading to a cascade of infant discomfort,Salvatore et al
- 2019 ORIGINAL ARTICLEScrying, parental anxiety, impaired quality of life, repeated
healthcare professional consultations, and escalating health-
care costs.4,8,20 Recognition of the exact prevalence of FGIDs
is important to plan a tailored program of parents’ education
and clinical follow-up. Furthermore, identification of associ-
ated neonatal risk factors for FGIDs represents an essential
prerequisite to develop possible early life interventions to
decrease FGIDs later in life.21,22
This study simultaneously assessed the effect of different
neonatal factors such as preterm birth, antibiotics therapy
during the first week of life, hospital stay, type of delivery,
and feeding pattern on to the development of FGIDs in in-
fants. To limit the cumulative effect of different risk factors
and to better clarify the major determinants for FGIDs, we
performed both univariate and multivariate statistical anal-
ysis. Moreover, we tried to recruit a large group of newborns
with different gestational ages and a subgroup of neonates
born full term exposed to antibiotic treatment at birth for
early life infection or for prevention of Group B Streptococcal
disease.
Early-life antibiotic use recently has been linked to an
increased risk of allergy23,24 and of inflammatory bowel
disease in genetically prone newborns.25 Both infections
and antibiotic early in life can determine immune dysregu-
lation, aberrant barrier functions, microbiota modification,
and altered gut sensorimotor functions that, in susceptible
individuals, may lead to FGIDs.12,26,27 Newborns born pre-
term represent an extraordinary population because of
increased exposure to early life infections and antibiotics,
traumatic and stress events, and prolonged hospital stay
with often maternal deprivation, all possible predisposing
factors for FGIDs. Noteworthy, the exposure of newborns
born preterm to acute painful stimuli can, per se, prolong
the period of hyperalgesia, which is one major determinant
of FGID.28,29
If the results of our study are confirmed, a balanced strat-
egy to reduce unnecessary neonatal antibiotic use and to pro-
mote intestinal homeostasis in at risk neonates should be
considered. Nonetheless, parental education and reassurance
on FGIDs and appropriate nutritional advice by healthcare
professionals could reduce the inappropriate use of medica-
tion or dietary interventions later in life.4
Strengths of our study include a large population of neo-
nates born both preterm and full term enrolled at birth and
prospectively followed up to 12 months of life, the multi-
center design, the analysis of different neonatal factors, and
the use of Rome III criteria to classify FGIDs. A major limi-
tation of our study is the lack of complete information about
the antibiotic treatments at birth and during the follow-up
period that did not allow a subgroup detailed analysis on
this associated factor. Moreover, the occurrence of viral in-
fections, probiotic administration, and other potential con-
founders such as neonatal gastric suction or other invasive
procedures, exposure to smoke, daycare attendance, feeding
characteristics, and family history of FGIDs were not consid-
ered. Other limitations were the possible influence of cow’s
milk protein allergy on FGIDs symptoms30 and observerNeonatal Antibiotics and Prematurity Are Associated with an Incr
the First Year of Lifebias due to the unblinding of the participants healthcare pro-
fessionals regarding the study outcomes. Finally, we fully
relied on parents’ reports, which generally overestimate
infant’s sympoms.8 Further follow-up also is needed to
determine whether FGIDs in infants persist into childhood,
adolescence, and adulthood and if intervention in potential
neonatal risk factor could reduce the burden of these
diseases.31-33
The perinatal period, being the time during which
maturation of the complex mechanisms that regulate the
braingutmicrobiota axis occurs, is a critical period in
which different determinants may have important later con-
sequences.34 We showed that preterm delivery and neonatal
use of antibiotics are significantly associated with an
increased incidence of FGIDs, and particularly of colic and
regurgitation in the first months of life. However, as the diag-
nosis of a FGID mainly relies on parental reports and inter-
pretation of symptoms, a greater incidence in infants born
preterm might be related to the coping style of parents, influ-
enced by the multiple stressful experiences related to the pre-
term delivery.35 Cesarean delivery, formula feeding, and
longer hospital stay at birth may represent additional risk fac-
tors for FGIDs and need to be further analyzed. Clarifying the
role of different potential risk factors during the neonatal
period may provide new insights in the pathogenesis of
FGIDs and indicate possible protective strategies. nWe thank Dr Giovanni Veronesi, who made valuable suggestions dur-
ing the preparation of the manuscript.
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